Immunogenicity of different stressed IgG monoclonal antibody formulations in immune tolerant transgenic mice.
Ontology highlight
ABSTRACT: The presence of protein aggregates in biopharmaceutical formulations is of great concern for safety and efficacy reasons. The aim of this study was to correlate the type and amount of IgG monoclonal antibody aggregates with their immunogenic potential. IgG degradation was obtained by freeze-thawing cycles, pH-shift cycles, heating, shaking and metal-catalyzed oxidation. The size, amount, morphology and type of intermolecular bonds of aggregates, as well as structural changes and epitope integrity were characterized. These formulations were injected in mice transgenic (TG) for human genes for Ig heavy and light chains and their non-transgenic (NTG) counterparts. Anti-drug antibody (ADA) titers were determined by bridging ELISA. Both unstressed IgG and freeze-thawed formulation did not induc
SUBMITTER: Filipe V
PROVIDER: S-EPMC3502241 | biostudies-literature | 2012 Nov-Dec
REPOSITORIES: biostudies-literature
ACCESS DATA